Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study

被引:6
|
作者
Deconinck, L. [1 ,2 ,5 ]
Yazdanpanah, Y. [2 ,3 ]
Gilson, R. J. [1 ,4 ]
Melliez, H. [5 ]
Viget, N. [5 ]
Joly, V. [3 ]
Sabin, C. A. [1 ]
机构
[1] UCL, UCL Res Dept Infect & Populat Hlth, London, England
[2] Paris Diderot Univ, Decis Sci Infect Dis Prevent Control & Care, IAME, Sorbonne Paris Cite,UMR 1137, Paris, France
[3] Bichat Claude Bernard Hosp, Dept Infect Dis, Paris, France
[4] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London, England
[5] Tourcoing Hosp, Lille Sch Med, Dept Infect Dis, Tourcoing, France
关键词
AIDS-related opportunistic infections; antiretroviral therapy; HIV; time to treatment; CONSEQUENCES; AIDS;
D O I
10.1111/hiv.12201
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
ObjectivesThe aim of the study was to identify factors associated with the time between opportunistic disease (OD) diagnosis and antiretroviral therapy (ART) initiation in HIV-infected patients presenting for care with an OD, and to evaluate the outcomes associated with any delay. MethodsA multicentre cohort study was undertaken in London, Paris and Lille/Tourcoing. The medical records of patients diagnosed from 2002 to 2012 were reviewed. ResultsA total of 437 patients were enrolled in the study: 70% were male, the median age was 40 years, 42% were from sub-Saharan Africa, 68% were heterosexual, the median CD4 count was 40cells/L, and the most common ODs were Pneumocystis pneumonia (37%), tuberculosis (24%), toxoplasmosis (12%) and Kaposi's sarcoma (11%). Of these patients, 400 (92%) started ART within 24 weeks after HIV diagnosis, with a median time from OD diagnosis to ART initiation of 30 [interquartile range (IQR) 16-58] days. Patients diagnosed between 2009 and 2012 had a shorter time to ART initiation than those diagnosed in earlier years [hazard ratio (HR) 2.07; 95% confidence interval (CI) 1.58-2.72]. Factors associated with a longer time to ART initiation were a CD4 count200cells/L (HR 0.30; 95% CI 0.20-0.44), tuberculosis (HR 0.40; 95% CI 0.30-0.55) and diagnosis in London (HR 0.62; 95% CI 0.48-0.80). Patients initiating deferred' ART (by 30 days) exhibited no difference in disease progression or immunovirological response compared with patients who had shorter times to ART initiation. Patients in the deferred' group were less likely to have ART modifications (HR 0.69; 95% CI 0.48-1.00) and had shorter in-patient stays (mean 14.2 days shorter; 95% CI 8.9-19.5 days) than patients in the group whose ART was not deferred. ConclusionsThe time between OD diagnosis and ART initiation remains heterogeneous and relatively long, particularly in individuals with a high CD4 count or tuberculosis or those diagnosed in London. Deferring ART was associated with fewer ART modifications and shorter in-patient stays.
引用
收藏
页码:219 / 229
页数:11
相关论文
共 50 条
  • [21] Operationalizing early antiretroviral therapy in HIV-infected in-patients with opportunistic infections including tuberculosis
    Sunpath, H.
    Edwin, C.
    Chelin, N.
    Nadesan, S.
    Maharaj, R.
    Moosa, Y.
    Smeaton, L.
    Court, R.
    Knight, S.
    Gwyther, E.
    Murphy, R. A.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (07) : 917 - 923
  • [22] The Effect of Antiretroviral Therapy Initiation on the Vaginal Microbiome in HIV-Infected Women
    Liu, Cindy M.
    Packman, Zoe R.
    Abraham, Alison G.
    Serwadda, David M.
    Nalugoda, Fred
    Aziz, Maliha
    Prodger, Jessica L.
    Kaul, Rupert
    Kalibbala, Sarah
    Gray, Ronald H.
    Price, Lance B.
    Quinn, Thomas C.
    Tobian, Aaron A. R.
    Reynolds, Steven J.
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (09):
  • [23] Antiretroviral therapy refusal among newly diagnosed HIV-infected adults
    Katz, Ingrid T.
    Essien, Thandekile
    Marinda, Edmore T.
    Gray, Glenda E.
    Bangsberg, David R.
    Martinson, Neil A.
    De Bruyn, Guy
    AIDS, 2011, 25 (17) : 2177 - 2181
  • [24] Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults
    Siegfried, Nandi
    Uthman, Olalekan A.
    Rutherford, George W.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (03):
  • [25] Effectiveness of Early Antiretroviral Therapy Initiation to Improve Survival among HIV-Infected Adults with Tuberculosis: A Retrospective Cohort Study
    Franke, Molly F.
    Robins, James M.
    Mugabo, Jules
    Kaigamba, Felix
    Cain, Lauren E.
    Fleming, Julia G.
    Murray, Megan B.
    PLOS MEDICINE, 2011, 8 (05)
  • [26] HIV-Infected Women Gain More Weight than HIV-Infected Men Following the Initiation of Antiretroviral Therapy
    Bares, Sara H.
    Smeaton, Laura M.
    Xu, Ai
    Godfrey, Catherine
    McComsey, Grace A.
    JOURNAL OF WOMENS HEALTH, 2018, 27 (09) : 1162 - 1169
  • [27] Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients
    Calza, L
    Manfredi, R
    Chiodo, F
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 10 - 14
  • [28] Gynecomastia in HIV-infected patients receiving antiretroviral therapy
    García-Benayas, T
    Blanco, F
    Martín-Carbonero, L
    Valencia, E
    Barrios, A
    González-Lahoz, J
    Soriano, V
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2003, 19 (09) : 739 - 741
  • [29] Thyroid screening in HIV-infected patients with antiretroviral therapy
    Margit Hatzl
    Angela Öllinger
    Maria Geit
    Klaus Wiesinger
    Kristina Angerbauer
    Josef Auböck
    Michael Gabriel
    Wiener klinische Wochenschrift, 2015, 127 : 601 - 605
  • [30] Thyroid screening in HIV-infected patients with antiretroviral therapy
    Hatzl, Margit
    Oellinger, Angela
    Geit, Maria
    Wiesinger, Klaus
    Angerbauer, Kristina
    Auboeck, Josef
    Gabriel, Michael
    WIENER KLINISCHE WOCHENSCHRIFT, 2015, 127 (15-16) : 601 - 605